GlassScriptPhysician profile
William S Craig
NPI 1417132192
$869.42
in general payments reported to CMS, 2019-2025
17 companies · $50.66 in 2025
The $50.66 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $67.89 · 2021: $91.82 · 2022: $72.06 · 2023: $99.95 · 2024: $148 · 2025: $50.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $148.38 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $96.60 | 2019-2021 | |
| Amgen INC. | $89.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $80.94 | 2019-2021 | |
| Abbott Laboratories | $60.35 | 2022 | |
| Astellas Pharma US INC | $57.89 | 2019-2020 | |
| Pfizer INC. | $56.80 | 2019 | |
| Dexcom, INC. | $46.86 | 2021 | |
| Lilly USA, LLC | $43.60 | 2022-2023 | Mounjaro, Trulicity |
| Medtronic, INC. | $39.48 | 2023 | Inpen Smart Insulin Delivery System |
| Glaxosmithkline, LLC. | $39.10 | 2019-2023 | Arexvy |
| Vertex Pharmaceuticals Incorporated | $32.80 | 2025 | |
| Merck Sharp & Dohme LLC | $17.86 | 2025 | Capvaxive, Vaxneuvance |
| Allergan, INC. | $15.44 | 2019 | |
| Novo Nordisk INC | $15.11 | 2023 | Rybelsus, Ozempic |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $14.92 | 2020 | |
| Medtronic Minimed, INC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Craig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.